Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Antivirals for influenza Like Illness? An rCt of Clinical and Cost effectiveness in primary CarE

Next Previous
Trial Profile

Antivirals for influenza Like Illness? An rCt of Clinical and Cost effectiveness in primary CarE

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Mar 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms ALIC4E

Most Recent Events

  • 01 Mar 2022 Results of post-hoc analysis determining whether clinical presentation and illness course differ between RTIs where a viral pathogen was detected and those where a potential bacterial pathogen was found, published in the British Journal of General Practice.
  • 01 Jul 2020 Results of post hoc exploratory analysis determining whether adding oseltamivir to usual care reduces time to recovery in symptomatic patients who have tested positive for coronavirus published in the British Journal of General Practice
  • 16 Dec 2019 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top